These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 20714078)
1. rTMS effects on levodopa induced dyskinesias in Parkinson's disease patients: searching for effective cortical targets. Koch G Restor Neurol Neurosci; 2010; 28(4):561-8. PubMed ID: 20714078 [TBL] [Abstract][Full Text] [Related]
2. Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's disease. Brusa L; Versace V; Koch G; Iani C; Stanzione P; Bernardi G; Centonze D Clin Neurophysiol; 2006 Sep; 117(9):1917-21. PubMed ID: 16887383 [TBL] [Abstract][Full Text] [Related]
3. Low-frequency repetitive transcranial magnetic stimulation for dyskinesia and motor performance in Parkinson's disease. Sayın S; Cakmur R; Yener GG; Yaka E; Uğurel B; Uzunel F J Clin Neurosci; 2014 Aug; 21(8):1373-6. PubMed ID: 24631324 [TBL] [Abstract][Full Text] [Related]
4. Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease. Koch G; Brusa L; Carrillo F; Lo Gerfo E; Torriero S; Oliveri M; Mir P; Caltagirone C; Stanzione P Neurology; 2009 Jul; 73(2):113-9. PubMed ID: 19597133 [TBL] [Abstract][Full Text] [Related]
5. Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's disease. Filipović SR; Rothwell JC; van de Warrenburg BP; Bhatia K Mov Disord; 2009 Jan; 24(2):246-53. PubMed ID: 18951540 [TBL] [Abstract][Full Text] [Related]
6. Bilateral low frequency rTMS of the primary motor cortex may not be a suitable treatment for levodopa-induced dyskinesias in late stage Parkinson's disease. Flamez A; Cordenier A; De Raedt S; Michiels V; Smetcoren S; Van Merhaegen-Wieleman A; Parys E; De Keyser J; Baeken C Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26777410 [TBL] [Abstract][Full Text] [Related]
7. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674 [TBL] [Abstract][Full Text] [Related]
8. Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment. Thanvi B; Lo N; Robinson T Postgrad Med J; 2007 Jun; 83(980):384-8. PubMed ID: 17551069 [TBL] [Abstract][Full Text] [Related]
9. Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias. Cerasa A; Salsone M; Morelli M; Pugliese P; Arabia G; Gioia CM; Novellino F; Quattrone A Parkinsonism Relat Disord; 2013 Oct; 19(10):883-8. PubMed ID: 23769805 [TBL] [Abstract][Full Text] [Related]
11. A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias. Cerasa A; Koch G; Donzuso G; Mangone G; Morelli M; Brusa L; Stampanoni Bassi M; Ponzo V; Picazio S; Passamonti L; Salsone M; Augimeri A; Caltagirone C; Quattrone A Brain; 2015 Feb; 138(Pt 2):414-27. PubMed ID: 25414038 [TBL] [Abstract][Full Text] [Related]
12. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease. Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021 [TBL] [Abstract][Full Text] [Related]
14. Prefrontal alterations in Parkinson's disease with levodopa-induced dyskinesia during fMRI motor task. Cerasa A; Pugliese P; Messina D; Morelli M; Gioia MC; Salsone M; Novellino F; Nicoletti G; Arabia G; Quattrone A Mov Disord; 2012 Mar; 27(3):364-71. PubMed ID: 22076870 [TBL] [Abstract][Full Text] [Related]
15. Morphological and electrophysiological changes in intratelencephalic-type pyramidal neurons in the motor cortex of a rat model of levodopa-induced dyskinesia. Ueno T; Yamada J; Nishijima H; Arai A; Migita K; Baba M; Ueno S; Tomiyama M Neurobiol Dis; 2014 Apr; 64():142-9. PubMed ID: 24398173 [TBL] [Abstract][Full Text] [Related]
16. Cerebellar and Motor Cortical Transcranial Stimulation Decrease Levodopa-Induced Dyskinesias in Parkinson's Disease. Ferrucci R; Cortese F; Bianchi M; Pittera D; Turrone R; Bocci T; Borroni B; Vergari M; Cogiamanian F; Ardolino G; Di Fonzo A; Padovani A; Priori A Cerebellum; 2016 Feb; 15(1):43-47. PubMed ID: 26542731 [TBL] [Abstract][Full Text] [Related]
17. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease. Lefaucheur JP; Drouot X; Von Raison F; Ménard-Lefaucheur I; Cesaro P; Nguyen JP Clin Neurophysiol; 2004 Nov; 115(11):2530-41. PubMed ID: 15465443 [TBL] [Abstract][Full Text] [Related]
18. Repetitive transcranial magnetic stimulation (rTMS) improves behavioral and biochemical deficits in levodopa-induced dyskinetic rats model. Ba M; Kong M; Guan L; Yi M; Zhang H Oncotarget; 2016 Sep; 7(37):58802-58812. PubMed ID: 27613848 [TBL] [Abstract][Full Text] [Related]
19. rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease. Koch G; Brusa L; Caltagirone C; Peppe A; Oliveri M; Stanzione P; Centonze D Neurology; 2005 Aug; 65(4):623-5. PubMed ID: 16116131 [TBL] [Abstract][Full Text] [Related]
20. L-dopa-induced dyskinesia and stereotactic surgery for Parkinson's disease. Guridi J; Obeso JA; Rodriguez-Oroz MC; Lozano AA; Manrique M Neurosurgery; 2008 Feb; 62(2):311-23; discussion 323-5. PubMed ID: 18382309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]